Not known Details About who makes the copyright pen
In March 2025, the company declared new strategies for just a direct-to-client offering of its Wegovy weight loss drug. The company recognized a fresh pharmacy, termed NovoCare, which would cost prospects $499 every month for access to the drug, below 50 percent the expense of the drug through other pharmaceutical distribution networks.[fifty three